Tag: best glaucoma doctor gurgaon

Why Do I Need Glaucoma Treatment If My Vision Seems Normal?

Glaucoma often causes permanent optic nerve damage long before noticeable vision loss develops. Treatment is designed to protect your future vision by slowing or preventing progression before symptoms appear, Dr Shibal Bhartiya explains.

Your vision feels fine. No pain, no blur, no obvious change. So why is your doctor urging treatment? This is the most common question glaucoma patients ask, and it deserves a direct, honest answer,

Glaucoma destroys your optic nerve silently. By the time you notice something is wrong, you have already lost nerve fibres that will never return. Treatment does not restore what is gone. It protects what remains.

The Vision You Have Now Is Not the Vision You Started With

Glaucoma removes peripheral vision first. Your central vision stays sharp until the disease is advanced. Your brain also compensates, filling in blind areas so skilfully that you do not notice them. You may have lost 30 to 40 percent of your optic nerve fibres before any symptom appears.

This is why “I can see fine” is not a safe reassurance in glaucoma. It reflects the vision that has survived, not the vision that has been lost.

Why Glaucoma Treatment Feels Unnecessary (And Why That Feeling Is Dangerous)

Glaucoma drops do not improve your vision. They do not reduce pain because glaucoma causes none. They do not change how things look today. Their only job is to lower the pressure inside your eye and slow the damage to your optic nerve.

When a treatment produces no felt benefit, stopping it feels harmless. This is the central psychological trap in glaucoma care. Patients who feel well skip doses, delay refills, or discontinue treatment altogether. The nerve continues to deteriorate. By the time symptoms appear, the loss is severe and permanent.

The absence of symptoms is not evidence that you are safe. It is evidence that the disease has not yet crossed your threshold of awareness.

What the Research Actually Shows

Studies consistently show that controlling eye pressure reduces the risk of glaucoma progression. The Ocular Hypertension Treatment Study showed that lowering pressure by 20 percent reduced conversion to glaucoma by more than half. The Early Manifest Glaucoma Trial showed that each mmHg reduction in pressure produced a measurable reduction in progression risk.

You are not treating a feeling. You are treating a measurable biological risk that happens to produce no warning before it causes irreversible harm.

“But My Pressures Are Controlled Now — Do I Still Need Drops?”

Yes. Controlled pressure means the treatment is working. Stopping treatment removes the protection. Pressure typically rises again within days to weeks after discontinuation.

Some patients assume that normal pressure readings mean the problem is resolved. Glaucoma is a chronic condition. Controlled pressure is a maintained state, not a cured one.

Normal-Tension Glaucoma: When Pressure Is Not Even the Full Story

A significant group of patients develop glaucoma with eye pressures in the statistically normal range. Their optic nerves are still vulnerable, often due to poor blood flow, structural susceptibility, or other factors. For these patients, the question “but my pressure is fine” does not mean treatment is unnecessary. It means the target pressure needs to be set lower, and other risk factors need attention.

This is one reason that glaucoma management requires individual assessment, not a one-size guideline.

FAQ

If I have no symptoms, does that mean my glaucoma is mild?

Not necessarily. Glaucoma can cause significant optic nerve damage before any symptom appears. The severity of glaucoma is assessed through structural tests like OCT and functional tests like visual fields, not through how your vision feels day to day.

What happens if I skip my glaucoma drops for a few days?

Eye pressure can rise within 24 to 48 hours of stopping treatment. Over time, this pressure exposure adds to cumulative nerve damage. Occasional missed doses are less harmful than long gaps, but no dose-skipping is risk-free in active glaucoma.

Can I know if my glaucoma is getting worse?

Progression is detected through serial OCT scans and visual field testing, not through symptoms. This is why regular follow-up is essential even when your vision feels unchanged.

My doctor wants to change my drops. Should I get a second opinion first?

A second opinion is always appropriate in glaucoma, especially if you are uncertain about treatment changes, surgical recommendations, or whether your current regimen is adequate. Glaucoma causes irreversible loss, so the cost of a wrong decision is permanent.

Are there people who do not need treatment despite a glaucoma diagnosis?

In very early suspected glaucoma or ocular hypertension with low risk factors, observation may be appropriate rather than immediate treatment. This is a clinical judgement based on your individual risk profile, your optic nerve appearance, and your visual field results. It requires an experienced glaucoma specialist to make that call correctly.

What You Should Expect From Your Glaucoma Care

A good glaucoma consultation does more than prescribe drops. It establishes your target pressure based on your stage of disease, your age, and your life expectancy. Also, it identifies your progression rate through serial testing. It reviews whether your current treatment is achieving that target. And it explains, clearly, what is at stake if treatment is inconsistent.

If you have left a consultation without understanding why your specific pressure target was chosen, that is worth asking about. If you are uncertain whether your glaucoma is stable or progressing, that is worth investigating through formal visual field and OCT trend analysis.

A Note on Seeking a Second Opinion

Glaucoma decisions carry permanent consequences. Second opinions are not a sign of distrust toward your current doctor. They are a rational response to a disease where the cost of under-treatment is irreversible. An independent review of your scans and pressure history can confirm that you are on the right path, or catch something that has been missed.

This page is part of the Glaucoma Hub hub. Read about our full approach to glaucoma care. Please also read our Second Opinion Hub. Please also read Glaucoma Diagnosis, first 90 days; and Glaucoma Treatment

Here’s another heartening patient story: Tired of drops

About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google

Glaucoma Diagnosis: First 90 Days

A glaucoma diagnosis can feel overwhelming, but the first 90 days are crucial for understanding your condition, starting treatment, and establishing a plan to protect your vision long term. Early follow-up, regular eye pressure monitoring, and clear communication with your glaucoma specialist can make a significant difference in preserving sight.

Your First 90 Days With Glaucoma: A Step-by-Step Action Plan

Many patients ask me: I have been diagnosed with glaucoma. What do I do now. Here is what I tell them: A glaucoma diagnosis does not mean you are going blind. It means you now have information most people get too late. The next 90 days are the most important window — not because the disease moves fast, but because the habits you build now protect your vision for the next 30 years.

This guide, written by Dr Shibal Bhartiya, tells you exactly what to do, in order.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.

Day 1–7 of Glaucoma Diagnosis: Get the Basics Right

Learn to put in your eye drops correctly

This is the single most important skill you will learn. Studies show that over 60% of patients use eye drops incorrectly — and incorrect technique means the drop misses the eye, or drains immediately into the tear duct and does nothing.

Do this:

Wash your hands. Tilt your head back. Pull your lower eyelid gently down to form a pocket. Hold the bottle above the eye without touching it. Squeeze one drop into the pocket — not onto the eyeball directly. Close your eye gently. Press the inner corner of your eye (near the nose) firmly with one finger for 60 seconds. This blocks the tear duct and keeps the drug in the eye where it belongs. Do not blink vigorously. Do not wipe.

If you use more than one drop type, wait five minutes between them. The first drop dilutes and flushes out the second if you use them together.

Ask your doctor or optometrist to watch you do it once. Ask for a correction if your technique needs adjustment.

Here’s a video demostration:

Set your alarms — and take them seriously

Glaucoma drops work only when taken on time, every day, for life. A single missed day matters less than a pattern of casual delays.

Most drops are once daily, ideally at night. Set a recurring alarm on your phone with a label — “Left eye drop, right eye drop, press corner.” Place the bottle next to your toothbrush. The habit links to the existing habit.

If you use drops twice daily, set both alarms. Never rely on memory alone.

File your papers before they disappear

You walked out of the clinic with reports. Photograph or scan every one of them today — the visual field test, the OCT nerve scan, the IOP readings, the prescription. Put them in a dedicated folder on your phone or email them to yourself with the subject line “Glaucoma Records — [your name].”

You will need these at your next visit, at any second opinion, and if you travel and need emergency eye care. Doctors cannot make good decisions without your baseline.

Week 2–4 of Glaucoma Diagnosis: Build the Follow-Up Structure

Your 30-day appointment is not optional

Glaucoma drops take four to six weeks to show their full pressure-lowering effect. Your doctor needs to see you at 30 days to measure whether the drop is working — and to catch side effects early. Do not skip this.

At this visit, your doctor will check:

  • Your intraocular pressure (IOP) against your baseline
  • Whether the drop is causing redness, allergy, or discomfort
  • Whether you need a dose adjustment or a switch to a different medication

Set a calendar reminder for this appointment the day you are diagnosed. If the appointment was not scheduled, call the clinic and schedule it yourself before the week is over.

Know what side effects to watch for

Most glaucoma drops are well-tolerated. But some cause changes you should know about.

Prostaglandin analogues (bimatoprost, travoprost, latanoprost) can darken the iris over time in some patients, and may cause eyelash growth or mild redness. These are cosmetic and not dangerous — but tell your doctor.

Beta-blockers (timolol) can slow your heart rate and cause breathlessness in patients with asthma or heart disease. If you feel unusually short of breath or very tired after starting drops, contact your doctor the same day.

Alpha agonists (brimonidine) sometimes cause an allergic reaction with marked redness and discharge, usually within weeks of starting. Stop the drop and call your doctor if this happens.

None of these mean you must stop treatment. They mean the treatment may need adjustment.

Month 1–2 of Glaucoma Diagnosis: Tell Your Family

Your siblings and children need an eye check — now

Glaucoma has a strong genetic component. First-degree relatives of a glaucoma patient have a four to nine times higher risk of developing the disease. Most of them will have no symptoms at all until damage is advanced.

Tell your siblings and adult children this week. Ask them to see an ophthalmologist for a baseline pressure check, optic nerve assessment, and field test. This is not alarmist. It is the most useful thing your diagnosis can do for your family.

Month 1–3: Address the Controllable Risk Factors

Stop smoking — this one is not negotiable

Smoking constricts blood vessels and reduces blood flow to the optic nerve. It worsens the vascular risk that many glaucoma patients already carry. The damage from smoking adds to the damage from pressure — and your nerve cannot absorb both.

If you smoke, speak to your doctor about cessation support. This is as important as the drops.

Get your metabolic parameters checked

High blood pressure, diabetes, thyroid disease, and sleep apnoea all affect glaucoma progression through vascular and metabolic pathways. If these are uncontrolled, your optic nerve faces risk from two directions simultaneously.

Ask your physician to check your blood pressure, fasting glucose, HbA1c, and thyroid function if these have not been done recently. If you snore heavily or feel exhausted in the mornings, mention it — untreated sleep apnoea is a recognised glaucoma risk factor that is almost always missed.

Exercise — the right kind

Moderate aerobic exercise (brisk walking 30 minutes, five days a week) lowers intraocular pressure by a clinically meaningful amount in most patients. Avoid high-resistance head-down exercises like heavy weightlifting or inverted yoga poses — these transiently spike IOP.

Month 2–3: Ask About Laser Treatment

SLT — Selective Laser Trabeculoplasty

If your glaucoma is open-angle type, your doctor may recommend SLT as a first-line treatment or as a supplement to drops. SLT uses a laser to improve fluid drainage from the eye. It is done in the clinic in five to ten minutes, is painless, and works in approximately 75 to 80% of patients.

The effect lasts three to five years and can be repeated. SLT does not burn tissue — it sends a gentle energy pulse that stimulates the drainage cells to work better.

Ask your doctor at the 30-day or 90-day visit: “Am I a candidate for SLT?”

LPI — Laser Peripheral Iridotomy

If your glaucoma is narrow-angle or angle-closure type, LPI is a preventive procedure that creates a small opening in the iris to prevent a sudden pressure spike (acute angle-closure attack). LPI is typically recommended before an attack happens — it takes three to four minutes per eye and prevents one of the most painful ophthalmic emergencies.

If your doctor mentioned narrow angles at any point, ask specifically whether you need LPI. Do not wait.

Throughout: Keep Your Perspective

Do not search the internet at 2am

Glaucoma outcomes in treated patients are overwhelmingly good. The disease moves slowly in the vast majority of cases. Patients who take their drops, attend follow-ups, and manage their risk factors maintain useful vision for life in most cases.

The stories of severe vision loss you will find online mostly involve patients who were never diagnosed, or who stopped treatment. You are neither.

Reach out if you need support

A new diagnosis changes how you think about your body. Some patients find this unsettling, and that is entirely normal. Several Indian and international glaucoma patient forums, and online communities run by ophthalmologists offer peer support from people at every stage of the same journey.

You do not have to figure this out alone.

Your 90-Day Checklist

  • Eye drop technique confirmed by a doctor or technician
  • Alarm set — every day, same time
  • All reports photographed and filed digitally
  • 30-day follow-up appointment booked
  • Side effects list saved on your phone
  • Siblings and adult children informed and booked for screening
  • Smoking cessation initiated if applicable
  • Blood pressure, glucose, HbA1c, thyroid checked
  • SLT or LPI discussion had with your doctor
  • One support resource bookmarked

Frequently Asked Questions

Do I have to take eye drops for life?

In most cases, yes. Glaucoma is a chronic condition and eye drops control pressure — they do not cure the disease. Stopping drops allows pressure to rise again and damage to resume. Some patients reduce or stop drops after successful laser treatment (SLT), but this is a decision made with your doctor based on your pressure readings, not independently.

What if I forget a drop one day?

Take it as soon as you remember, unless it is almost time for the next dose. Do not double up. One missed dose will not cause a crisis. A habit of casual misses will. Reset the alarm and continue.

Can I drive after putting in my eye drops?

Most glaucoma drops do not affect vision significantly. Some patients notice mild blurring for a few minutes immediately after instillation — wait for this to clear before driving. If your doctor has dilated your pupils at a clinic visit, do not drive until dilation wears off, typically three to four hours.

My pressure was normal at diagnosis. Do I still have glaucoma?

Yes — this is called normal-tension glaucoma (NTG). Roughly 30 to 40% of glaucoma patients in India have pressures within the statistical normal range. The diagnosis is made on optic nerve appearance and visual field changes, not pressure alone. NTG is treated the same way — the target is to lower pressure further from your individual baseline.

Is glaucoma hereditary? Do I need to tell my family?

Yes, and yes. First-degree relatives — parents, siblings, children — have a four to nine times higher risk. Most will have no symptoms. Tell them this week and ask them to see an ophthalmologist for a baseline check that includes pressure, nerve assessment, and a visual field test.

Will I go blind?

Treated glaucoma in a compliant patient who attends follow-up carries a very low risk of blindness. The risk is real only when the disease is undiagnosed, undertreated, or ignored. You have been diagnosed. That is the most important step already taken.

What is SLT and should I ask about it?

Selective Laser Trabeculoplasty (SLT) is a five-minute clinic procedure that improves fluid drainage from the eye. It works in approximately 75 to 80% of open-angle glaucoma patients and can reduce or eliminate the need for drops for three to five years. Ask your doctor at the 30-day visit whether you are a candidate.

Can I exercise with glaucoma?

Yes — moderate aerobic exercise is actively beneficial and lowers IOP. Brisk walking, cycling, and swimming are all good. Avoid heavy resistance training with breath-holding (Valsalva manoeuvre) and inverted positions, both of which spike pressure transiently. If exercise is a regular part of your routine, tell your doctor so they can factor it into your pressure readings.

My drops are making my eyes red. Should I stop?

Do not stop without speaking to your doctor first. Redness is common with several drop classes and is often manageable — a preservative-free formulation or a switch in medication resolves it in most cases. Stopping drops independently allows pressure to rise. Call the clinic and describe the symptom.

How often will I need follow-up forever?

Once stable on treatment, most patients are reviewed every three to six months. This includes a pressure check and, once yearly or more often if needed, a repeat visual field test and OCT nerve scan to confirm the disease is not progressing. Glaucoma never becomes self-managing — the follow-up rhythm continues for life, but it is not onerous once the initial titration phase is complete.

This page is part of the Glaucoma Hub hub. Read about our full approach to glaucoma care and monitoring. Please also read our guide to Understanding Your Visual Field Test. You may want to read a patient’s experience with glaucoma eye drops, and of one with SLT.

About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google

Optic Nerve Cupping: What Does It Mean When Your Doctor Says Your Cup Is Large?

Optic nerve cupping refers to the size of the central hollow, the cup, within the optic disc at the back of your eye. A large cup does not automatically mean glaucoma, but it is one of the most important findings an eye doctor can make, and it always warrants a thorough explanation.

If you have been told your cup-to-disc ratio is large, or that your optic nerve looks suspicious, this article explains exactly what that means and what happens next.

Understanding the Optic Disc and the Cup

The optic disc is the point where the optic nerve exits the eye, visible as a small, pale, circular structure at the back of the retina. Within this disc is a central depression called the cup. The rim of neural tissue surrounding the cup, the neuroretinal rim, contains the nerve fibres that carry visual information from the retina to the brain.

The cup-to-disc ratio (CDR) describes the size of the cup relative to the overall disc. A CDR of 0.3 means the cup occupies 30 percent of the disc diameter. A CDR of 0.7 means the cup occupies 70 percent.

Normal CDR values vary widely in the population. Most people have a CDR between 0.1 and 0.5. A CDR above 0.6 is considered large and warrants assessment, though it is not in itself a diagnosis. What matters is not just the size of the cup, but the thickness and health of the rim surrounding it.

Why Cupping Happens

Physiological cupping — large but healthy Many people are simply born with a large optic disc and a correspondingly large cup. In these individuals, the neuroretinal rim is intact, the cup has a regular shape, and there is no evidence of nerve fibre loss on OCT or visual field testing. This is called physiological cupping. It requires monitoring, because a large cup makes subtle glaucomatous changes harder to detect, but it is not a disease.

Glaucomatous cupping — the cup enlarging over time In glaucoma, the elevated intraocular pressure damages and kills the nerve fibres in the neuroretinal rim. As fibres are lost, the rim thins and the cup expands, the process called cupping progression. The cup does not just become larger; it changes shape. The rim becomes notched, particularly at the superior and inferior poles where glaucoma tends to strike earliest. The blood vessels at the disc margin may be pushed to one side, a finding called bayoneting, and small haemorrhages may appear at the disc margin.

Glaucomatous cupping is permanent. The nerve fibres that are lost do not return. This is why early detection and pressure control, before significant cupping occurs, is the entire goal of glaucoma management.

Other causes of cupping Non-glaucomatous optic neuropathies can cause cupping that superficially resembles glaucomatous damage. Anterior ischaemic optic neuropathy, a stroke of the optic nerve, can produce cupping with a characteristic pattern of visual field loss. Compressive lesions behind the eye, tumours pressing on the optic nerve or chiasm, can also cause the cup to appear enlarged as nerve tissue is lost. This is one reason a suspicious optic disc always prompts a full assessment rather than an assumption of glaucoma.

What a Large CDR Means in Practice

Being told you have a large cup-to-disc ratio is the beginning of a clinical question, not the end of one. The question is: is this cup large because you were born that way, or because nerve tissue has been lost?

Answering this question requires:

Intraocular pressure measurement: to assess whether pressure is elevated and contributing to nerve damage.

OCT of the optic nerve and retinal nerve fibre layer (RNFL): to measure the actual thickness of the nerve tissue surrounding the cup. OCT can detect thinning before it is visible clinically or before it affects the visual field. A large cup with normal OCT thickness is reassuring. A large cup with thinned RNFL is a significant finding.

Visual field testing: to determine whether the nerve damage, if any, has translated into measurable loss of peripheral vision.

Gonioscopy: Examination of the drainage angle of the eye to assess the type of glaucoma. And to assess whether the angle is open or narrow.

Disc photography or OCT disc imaging: to document the current appearance and establish a baseline for future comparison. Change over time is often more meaningful than a single measurement.

Central corneal thickness: because a thin cornea gives falsely low pressure readings. A patient with a large cup and a thin cornea has a higher true IOP burden than the measured number suggests.

The Cup-to-Disc Ratio Is Not the Whole Story

Experienced glaucoma specialists look beyond the CDR number at several disc features that carry independent diagnostic weight:

Rim thinning — the neuroretinal rim should be thickest at the inferior and superior poles (following the ISNT rule: Inferior > Superior > Nasal > Temporal). Reversal of this pattern, particularly inferior or superior notching, is a red flag regardless of the overall CDR.

Disc haemorrhages — a small splinter-shaped bleed at the disc margin is one of the strongest single predictors of glaucoma progression. It is easily missed on a quick fundus examination and requires careful, dilated disc inspection to detect.

Peripapillary atrophy (PPA) — a zone of pale, thinned retina around the optic disc. Beta-zone PPA, adjacent to the disc, is associated with glaucoma and with areas of RNFL thinning. Its presence and extent add diagnostic information.

Vessel position and bayoneting — Displacement of vessels to the nasal side of the disc as the cup expands is a clinical sign of significant cupping.

Asymmetry between the two eyes — A CDR difference of 0.2 or more between the two eyes is clinically significant even if both values appear within normal limits individually. The eyes should be symmetric; asymmetry raises suspicion.

What Doctors Often Miss Telling You

  • A large CDR in one examination is a starting point, not a conclusion. The most important question is whether it is the same as last year, or larger. Without a baseline photograph or OCT, it is impossible to know. If you have never had disc imaging, ask for it.
  • Disc haemorrhages are transient and easily missed. They disappear within six to twelve weeks. A patient who has a haemorrhage between appointments may never have it documented unless the timing is right. If you notice a sudden change in your vision between appointments, attend sooner.
  • Physiological large cups run in families. If your parent or sibling has been told they have a large cup and investigated thoroughly, and found to be normal, your large cup is more likely physiological. But it still requires proper documentation.
  • You can have glaucoma with a normal CDR. Normal-tension glaucoma, is a type of glaucoma where pressure is within the statistically normal range. It is defined by optic nerve damage and visual field loss despite a pressure that would not be flagged as elevated. The disc changes are real; the pressure number is misleading. A normal IOP does not rule out glaucoma.
  • Race affects optic disc size. People of African descent tend to have larger optic discs, and therefore larger physiological cups, than people of European or Asian descent. A CDR of 0.7 in a Black patient may be completely physiological. However, the same value in a patient of East Asian descent warrants more careful scrutiny. Normative databases used in OCT analysis are population-specific for this reason.

When to Worry

Seek assessment promptly, ideally within days, not weeks, if you notice:

  • A new area of missing or dim vision in any part of your visual field
  • Blurring that is worse in one eye than the other and was not present before
  • A shadow, curtain, or arc of darkness at the edge of your vision
  • A sudden change in colour perception in one eye
  • You have been told in the past that your optic nerve looks suspicious but have never had a full glaucoma workup including OCT and visual fields

If your large cup has never been formally investigated with IOP, OCT, and visual field testing, that assessment is overdue regardless of how long ago you were told about it.

Frequently Asked Questions

What is a normal cup-to-disc ratio?

Most people have a cup-to-disc ratio between 0.1 and 0.5. A CDR above 0.6 is considered large and warrants assessment, though it is not automatically abnormal. What matters is the health of the surrounding neuroretinal rim, the OCT thickness, and the visual field, not the CDR number alone.

Does a large cup-to-disc ratio mean I have glaucoma?

Not necessarily. A large cup can be physiological, simply part of your normal anatomy, or it can indicate glaucomatous damage. Distinguishing between the two requires a full assessment including IOP, OCT, visual field testing, and disc imaging. A single number does not make a diagnosis.

Can optic nerve cupping be reversed?

Glaucomatous cupping, caused by irreversible nerve fibre loss, cannot be reversed. Lowering intraocular pressure stops further damage but does not restore what has already been lost. Some apparent reversal of cupping has been reported in infants and young children after IOP reduction, but this is not observed reliably in adults.

How is optic nerve cupping monitored?

Serial OCT scans of the optic nerve head and retinal nerve fibre layer, combined with visual field testing, are the standard monitoring tools. Disc photographs provide a qualitative record. The goal is to detect any progressive thinning of the neuroretinal rim or worsening of the visual field before vision loss becomes symptomatic.

Can I have a large cup and never develop glaucoma?

Yes. Many people with large physiological cups live their entire lives without developing glaucoma. The cup requires monitoring, ideally with baseline OCT and periodic review, but large cup size alone does not predict disease. The risk is that subtle early glaucomatous changes are harder to detect against the background of an already-large cup. This is why careful long-term follow-up is important.

What is the difference between a large cup and glaucoma?

Glaucoma is a disease of progressive optic nerve damage, defined by characteristic structural changes (thinning of the neuroretinal rim, RNFL loss) combined with corresponding functional changes (visual field defects). A large cup-to-disc ratio is an anatomical observation. Glaucoma requires evidence of damage and, in most cases, a pressure that is too high for that particular optic nerve. The two frequently overlap, but they are not the same thing.

Speak to a Specialist

If you have been told your cup is large, your optic nerve looks suspicious, or your CDR has changed, and you have not had a complete glaucoma workup, that assessment is the right next step. A large cup investigated thoroughly and found to be healthy is genuinely reassuring. A large cup that turns out to be early glaucoma, caught before the visual field is affected, is a vision-saving finding.

Book a consultation: +91 88826 38735 | www.drshibalbhartiya.com

Upload your OCT reports, disc photographs, and visual field results through the website before your appointment.

About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Access her work on Pubmed, Google Scholar, ResearchGate and ORCID.

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
 +91 88826 38735

1500+ Five Star Patient Reviews Google Business Profile

Upload your reports for a structured review.

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

PubMed Profile | Google Scholar | ResearchGate | ORCID

⭐ Helped by this article? Leave a Google review — it helps other patients find reliable eye care.

📋 Upload your reports for review before your appointment at www.drshibalbhartiya.com

📞 +91 88826 38735

Why Is My Vision Blurry in the Morning?

Blurred vision in the morning is often temporary—but recurring morning blur can be linked to dry eyes, corneal swelling, tear film changes, eye pressure fluctuations, sleep-related eye exposure, or underlying eye conditions. If your vision takes time to “clear up” after waking, keeps happening, or is affecting one eye more than the other, an eye examination may help identify whether this is a surface issue, focusing change, or something deeper needing evaluation, explains Dr Shibal Bhartiya.

Morning blur is common and almost always has a specific, identifiable cause. The eye is a dynamic system — overnight changes in tear film, IOP, corneal hydration, and lens status, all influence how clearly you see when you first wake up. Most causes are benign. A few are worth investigating.

Why vision is different on waking

During sleep the eyes are closed, the tear film is not renewed by blinking, the cornea absorbs slight fluid, and IOP follows a circadian pattern — typically peaking in the early morning hours. Waking vision reflects this overnight state before the eye re-equilibrates. For most people this lasts seconds to a few minutes. Prolonged morning blur — lasting more than 5–10 minutes — warrants assessment.

Common causes

1. Dry eye — the most common cause During sleep, especially if the eyelids do not close fully (nocturnal lagophthalmos), the ocular surface dries out. Waking produces burning, blurred vision, and redness that takes several minutes to settle after blinking. Lubricating gel drops at bedtime significantly reduce morning symptoms.

2. Morning IOP peak — relevant in glaucoma IOP follows a diurnal rhythm — highest in the early morning hours in most people. In glaucoma patients with borderline pressure control, this morning IOP peak can produce transient blur or the appearance of halos. This is clinically important and a reason why 24-hour IOP profiling (home tonometry or overnight clinic assessment) is more informative than a single afternoon reading.

3. Fuch’s endothelial dystrophy The corneal endothelium pumps fluid out of the cornea overnight. In Fuch’s dystrophy, this pump fails — fluid accumulates during sleep, causing the cornea to swell (corneal oedema). Morning blur is the hallmark symptom — vision is worst on waking and clears over 1–2 hours as the cornea dehydrates during the day. Diagnosed on slit-lamp examination. Treated definitively with DSAEK or DMEK corneal transplant surgery.

4. Contact lens complications Sleeping in contact lenses — even those marketed as extended-wear — reduces corneal oxygen overnight. Morning redness, blur, and discomfort result. Habitual overnight lens wear significantly increases the risk of infectious keratitis.

5. Blood sugar fluctuation in diabetes Blood glucose is often lowest in the early morning (or highest, depending on the pattern). These glucose fluctuations cause lens swelling and refractive shifts. Diabetics may notice that morning vision is consistently different from afternoon vision — clearer or blurrier depending on their glucose pattern overnight.

6. Medication eye drops — timing effect Certain glaucoma drops (particularly prostaglandin analogues used once daily at night) produce a transient mild blur as they work. This is harmless and typically resolves within minutes. If blur is more significant or prolonged, review with your ophthalmologist.

Symptoms and What They Mean

What You NoticeWhat It May Feel LikeWorth Discussing If…
Vision is blurry only when you wake upEyes take time to “clear” in the morningSymptoms are becoming more frequent
Vision improves after blinking or moving aroundTemporary fogginess or visual adjustmentOne eye is consistently worse
Reading feels harder early in the dayDifficulty focusing despite enough sleepDaily tasks are becoming affected
Eyes feel dry or uncomfortable on wakingGrittiness, irritation, fluctuating claritySymptoms return every morning
Vision seems normal in clinic but different at homeFeeling that something is “off” despite normal testsYou are changing glasses often without relief
Morning blur is new or unexplainedConcern that vision feels different than beforeSymptoms are persistent or worsening

When to investigate morning blur

Investigate if: morning blur lasts more than 10–15 minutes consistently, if it is in one eye only, if it has been getting progressively worse, if it is accompanied by pain or halos, or if you have known glaucoma or diabetes.

Fuch’s dystrophy in particular is underdiagnosed — it is often attributed to “just dry eyes” until vision deteriorates significantly. Any patient with blur that is consistently worst in the morning and improves through the day should have corneal endothelial assessment.

Persistent morning blur is not something to dismiss. Dr Shibal Bhartiya offers corneal, glaucoma, and dry eye assessment in Gurgaon — with 24-hour IOP profiling available for glaucoma patients with suspected morning pressure peaks. 📞 +91 88826 38735 | www.drshibalbhartiya.com

FAQs

Is blurry vision in the morning normal?

Occasional mild blur can happen, but persistent or recurring morning blur deserves attention—especially if it is new or worsening.

Can dry eyes cause blurry vision after waking up?

Yes. Tear film changes overnight can sometimes make vision feel temporarily blurred on waking.

Why does my vision improve later in the day?

Some people notice symptoms settle as the eyes adjust, blink more, or visual demands change during the day.

Should I worry if my eye test was normal?

Not necessarily—but if your visual experience feels different from what the test suggests, a more detailed evaluation may help.

When should I get blurry morning vision checked?

If it is frequent, getting worse, affects one eye more than the other, or is associated with discomfort or changes in everyday vision, it is worth discussing with an eye specialist.

About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google

Glaucoma Laser To Avoid Eye Drops

Selective Laser Trabeculoplasty (SLT) is a safe, non-invasive glaucoma laser treatment that can help lower eye pressure and reduce or delay the need for daily eye drops in selected patients. Early treatment decisions in glaucoma are about long-term pressure control, preserving vision, and reducing treatment burden—not just avoiding medication.

Standard glaucoma management assumes patients can put eyedrops. Patients with severe rheumatoid arthritis, osteoarthritis, or neurological tremors frequently cannot accurately administer daily eye drops. Recognising these physical limitations is a clinical responsibility. Selective Laser Trabeculoplasty (SLT) serves as an elite, non-invasive primary or adjunctive intervention that lowers intraocular pressure and eliminates the physical burden of drop compliance entirely.

THE ARTHRITIC HAND

Selective Laser Trabeculoplasty (SLT) To Avoid Glaucoma Eye Drops

A 78-year-old grandmother sat in my examination chair, her pressures were not controlled despite using eye drops. She had come for a second opinion. I asked her if she has used her eye drops. She said yes.

I happened to look at her hands, severely twisted by advanced rheumatoid arthritis.

Can you show me how you put eyedrops? She said she wasn’t carrying hers. I handed her a bottle of lubricating eyedrops.

She looked at me with tears in her eyes. Despite her absolute best efforts, her fingers lacked the strength to squeeze the bottle cleanly. Half the medication ran down her cheek every time.

No wonder her intraocular pressures swung unpredictably. Her remaining optic nerve fibres were quietly at risk.

We discussed options then, and she said she wanted to come back in two weeks. I was ready to wait. I performed Selective Laser Trabeculoplasty — a gentle, non-invasive outpatient procedure that takes under ten minutes. The laser targets specific cells in the eye’s drainage network, stimulating the body’s natural cleanup response to improve fluid outflow. Her intraocular pressure dropped into the ideal target zone.

She left the clinic that day free from drop bottles for the first time in years.

True medical accessibility means tailoring the science to fit the physical reality of the person in front of you.

I was one of the first eye doctors in India to offer SLT, fresh after my training at the University of Geneva. Here is an old video of mine from 2011, explaining my treatment philosophy after SLT.

Watch the video here.

FAQs

Can SLT laser replace glaucoma eye drops?

For some patients, SLT (Selective Laser Trabeculoplasty) can reduce or delay the need for glaucoma eye drops. Others may still need drops later depending on eye pressure, glaucoma type, and long-term response.

Is SLT painful?

SLT is usually well tolerated. The procedure is performed in the clinic, takes only a few minutes, and most people experience little to no discomfort.

How long does SLT last?

The pressure-lowering effect of SLT can last months to years and varies between individuals. In some cases, the laser may be repeated if appropriate.

Does SLT cure glaucoma?

No. SLT does not cure glaucoma or restore vision already lost. Its role is to lower eye pressure and help reduce the risk of future glaucoma progression.

How does SLT laser work to lower eye pressure?

SLT delivers precise, low-energy pulses to the trabecular meshwork — the eye’s internal drainage system. The laser selectively targets pigmented cells, stimulating a natural renewal process that clears microscopic blockages and allows fluid to drain more freely. It does not damage surrounding healthy tissue.

Is SLT a permanent replacement for daily glaucoma drops?

For many patients, SLT successfully controls intraocular pressure for several years, reducing or eliminating the need for daily drops. The effect can diminish over time, but the gentle nature of the procedure allows it to be safely repeated. Your specialist will monitor pressure and advise accordingly.

This page is part of the Advanced Glaucoma Care hub. Read about the full spectrum of glaucoma diagnosis and treatment.

About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google